We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

45 hedge funds and large institutions have $56.8M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 52 → 45 (-7)

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

32% less capital invested

Capital invested by funds: $83.8M → $56.8M (-$27M)

47% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 15

Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
8
Reduced
15
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$4.68M
2
NM
Newtyn Management
New York
+$1.55M
3
LCM
Laurion Capital Management
New York
+$918K
4
Renaissance Technologies
Renaissance Technologies
New York
+$637K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$579K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$12.6M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.49M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.61M
4
BlackRock
BlackRock
New York
-$1.18M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$380K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
ACT Capital Management
Pennsylvania
$45K – – –
B
27
Bailard
California
$42K +$35.5K +13,900 New
Northern Trust
28
Northern Trust
Illinois
$39K -$319K -125,069 -90%
CSS
29
Cubist Systematic Strategies
Connecticut
$34K -$3.3K -1,291 -10%
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$34K +$28.8K +11,274 New
E
31
Ergoteles
New York
$31K +$26.2K +10,278 New
TRCT
32
Tower Research Capital (TRC)
New York
$18K +$3.68K +1,442 +32%
CC
33
Cannell Capital
Wyoming
$12K +$9.94K +3,891 New
SPIA
34
Steward Partners Investment Advisory
New York
$7K – – –
JP Morgan Chase
35
JP Morgan Chase
New York
$4K -$29.4K -11,519 -89%
Citigroup
36
Citigroup
New York
$3K -$1.39K -545 -37%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$1K -$14.8K -5,789 -97%
PA
38
Parallel Advisors
California
$1K +$1.19K +464 New
RCM
39
RA Capital Management
Massachusetts
– -$12.6M -3,350,506 Closed
Janus Henderson Group
40
Janus Henderson Group
United Kingdom
– -$6.49M -1,719,610 Closed
Citadel Advisors
41
Citadel Advisors
Florida
– -$162K -42,746 Closed
Charles Schwab
42
Charles Schwab
California
– -$158K -41,838 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$94K -25,005 Closed
JF
44
Jump Financial
Illinois
– -$80K -21,300 Closed
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
– -$47K -12,555 Closed
CC
46
Centiva Capital
New York
– -$45K -11,856 Closed
N
47
Nuveen
North Carolina
– -$48K -10,992 Closed
AIG
48
American International Group
New York
– -$35K -9,273 Closed
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
– -$30K -7,860 Closed
Deutsche Bank
50
Deutsche Bank
Germany
– -$17K -4,476 Closed
1
2
3

CYT Hedge Fund Activity: Q2 2022 in Review

45 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q2 2022, worth a combined $56.8M — down 32% from $83.8M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CYT and 14 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 8 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $4.68M. The largest seller was RA Capital Management, exiting entirely with an estimated $12.6M sold.

  • 45 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q2 2022, down from 52 in Q1 2022.
  • Funds reported $56.8M of Cyteir Therapeutics, Inc. Common Stock stock for Q2 2022, down 32% quarter-over-quarter.
  • 14 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q2 2022 and 19 closed out, a net change of -5 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q2 2022 was Baker Bros. Advisors, an estimated $4.68M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q2 2022 was RA Capital Management, an estimated $12.6M sold.

Based on aggregated 13F filings for Q2 2022.